Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

H-1337

Aliases
H-1337 0.6%, H-1337 1.0%, H-1337 Placebo

1 clinical trial

2 indications

Indication
Glaucoma
Indication
ocular hypertension
Clinical trial
A Phase 2b Randomized, Double-masked, Active-controlled, Dose-response Study of the Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension
Status: Recruiting, Estimated PCD: 2025-12-01